دورية أكاديمية
A novel prognostic model based on AFP, tumor burden score and Albumin-Bilirubin grade for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
| العنوان: | A novel prognostic model based on AFP, tumor burden score and Albumin-Bilirubin grade for patients with hepatocellular carcinoma undergoing radiofrequency ablation. |
|---|---|
| المؤلفون: | Huang J; Department of Medical Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China., Cui W; Department of Interventional Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, P.R. China., Xie X; Department of Medical Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China., Lin K; Department of Medical Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China., Jin D; Department of Medical Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China., Xie X; Department of Medical Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China., Zhuang B; Department of Medical Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China. |
| المصدر: | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2256498. Date of Electronic Publication: 2023 Sep 21. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8508395 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5157 (Electronic) Linking ISSN: 02656736 NLM ISO Abbreviation: Int J Hyperthermia Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: London : Informa Healthcare Original Publication: London ; Philadelphia : Taylor & Francis, c1985- |
| مواضيع طبية MeSH: | Carcinoma, Hepatocellular*/diagnosis , Carcinoma, Hepatocellular*/surgery , Liver Neoplasms*/diagnosis , Liver Neoplasms*/surgery , Radiofrequency Ablation*, Humans ; Albumins ; alpha-Fetoproteins ; Bilirubin ; Prognosis ; Retrospective Studies ; Tumor Burden |
| مستخلص: | Purpose: The aim of this study was to develop prognostic scores, including the tumor burden score (TBS) and albumin-bilirubin (ALBI) grade, for evaluating the outcomes of hepatocellular carcinoma (HCC) patients after radiofrequency ablation (RFA). Materials and Methods: This retrospective study enrolled treatment-naïve HCC patients with BCLC 0-A who underwent RFA between January 2009 and December 2019. Regular follow-up was conducted after RFA to determine progression-free survival (PFS) and overall survival (OS). The patients were randomly allocated to the training or validation datasets in a 1:1 ratio. Preoperative prognostic scores were developed based on the results of multivariate analysis. The discriminatory ability of the scores was assessed using time-dependent AUC and compared with other models. Results: Serum alpha-fetoprotein (AFP) level and TBS were identified as independent prognostic factors for PFS, while serum AFP, TBS, and ALBI were identified as independent prognostic factors for OS in HCC patients after RFA. The time-dependent AUCs of the AFP-TBS score for the 1-, 3-, and 5-year PFS were 0.651, 0.667, and 0.620, respectively, in the training set, and 0.657, 0.687, and 0.704, respectively, in the validation set. For the 1-, 3-, and 5-year OS, the time-dependent AUCs were 0.680, 0.712, and 0.666, respectively, in the training set, and 0.712, 0.706 and 0.726 in the validation set for the AFP-TBS-ALBI score (ATA). The C-indices and AIC demonstrated that the scores provided better clinical benefits compared to other models. Conclusion: The ATA/AT score, derived from clinical and objective laboratory variables, can assist in individually predicting the prognosis of HCC patients undergoing curative RFA. |
| فهرسة مساهمة: | Keywords: Tumor burden; alpha fetoprotein; hepatocellular carcinoma; prognosis; radiofrequency ablation |
| المشرفين على المادة: | 0 (Albumins) 0 (alpha-Fetoproteins) RFM9X3LJ49 (Bilirubin) |
| تواريخ الأحداث: | Date Created: 20230921 Date Completed: 20230922 Latest Revision: 20230922 |
| رمز التحديث: | 20230922 |
| DOI: | 10.1080/02656736.2023.2256498 |
| PMID: | 37733400 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher 
Full Text Finder | تدمد: | 1464-5157 |
|---|---|
| DOI: | 10.1080/02656736.2023.2256498 |